期刊文献+

Histone Deacetylase Inhibitor SAHA Induces Expression of Fatty Acid-Binding Protein 4 and Inhibits Replication of Human Cytomegalovirus 被引量:1

原文传递
导出
摘要 Suberoylanilide hydroxamic acid(SAHA) is a histone deacetylase inhibitor that shows marked efficacy against many types of cancers and is approved to treat severe metastatic cutaneous T-cell lymphomas. In addition to its anticancer activity,SAHA has significant effects on the growth of many viruses. The effect of SAHA on replication of human cytomegalovirus(HCMV) has not, however, been investigated. Here, we showed that the replication of HCMV was significantly suppressed by treatment with SAHA at concentrations that did not show appreciable cytotoxicity. SAHA reduced transcription and protein levels of HCMV immediate early genes, showing that SAHA acts at an early stage in the viral life-cycle. RNAsequencing data mining showed that numerous pathways and molecules were affected by SAHA. Interferon-mediated immunity was one of the most relevant pathways in the RNA-sequencing data, and we confirmed that SAHA inhibits HCMV-induced IFN-mediated immune responses using quantitative Real-time PCR(qRT-PCR). Fatty acid-binding protein 4(FABP4), which plays a role in lipid metabolism, was identified by RNA-sequencing. We found that FABP4 expression was reduced by HCMV infection but increased by treatment with SAHA. We then showed that knockdown of FABP4 partially rescued the effect of SAHA on HCMV replication. Our data suggest that FABP4 contributes to the inhibitory effect of SAHA on HCMV replication.
出处 《Virologica Sinica》 SCIE CAS CSCD 2021年第6期1352-1362,共11页 中国病毒学(英文版)
基金 This research was supported by National Key R&D Program of China Grant(2016YFA0502101) National Natural Science Foundation of China(grants 81371826 and 81572002 to Z.Q.,grants 31300148 and 31570169)。
  • 相关文献

参考文献1

二级参考文献21

  • 1庄辉.慢性乙型肝炎病毒感染及其防治[J].中华肝脏病杂志,2005,13(5):324-325. 被引量:35
  • 2Ki CheongPark,Seung WonKim,Ji HyunPark,Eun HyeSong,Jeong WonYang,Hyun JooChung,Hye JinJung,Jin SuckSuh,Ho JeongKwon,Seung HoonChoi.Potential anti‐cancer activity of N‐hydroxy‐7‐(2‐naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in?vitro and in?vivo[J].Cancer Science.2011(2)
  • 3Eun Kyung Kim,Eui-Ju Choi.Pathological roles of MAPK signaling pathways in human diseases[J].BBA - Molecular Basis of Disease.2010(4)
  • 4Moo Rim Kang,Jong Soon Kang,Sang-Bae Han,Jang Hyun Kim,Dong-Myung Kim,Kiho Lee,Chang Woo Lee,Ki Hoon Lee,Chul Ho Lee,Gyoonhee Han,Jong Seong Kang,Hwan Mook Kim,Song-Kyu Park.A novel δ-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells[J].Biochemical Pharmacology.2009(5)
  • 5Cheng Sun,Jia Zhou.Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2[J].Biochemical Pharmacology.2008(1)
  • 6Chie Nishioka,Takayuki Ikezoe,Jing Yang,Seisho Takeuchi,H. Phillip Koeffler,Akihito Yokoyama.MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells[J].Leukemia Research.2008(9)
  • 7C.Habold,A.Poehlmann,K.Bajbouj,R.Hartig,K.S.Korkmaz,A.Roessner,R.Schneider‐Stock.Trichostatin A causes p53 to switch oxidative‐damaged colorectal cancer cells from cell cycle arrest into apoptosis[J].Journal of Cellular and Molecular Medicine.2007(2)
  • 8Ricky W Johnstone,Jonathan D Licht.Histone deacetylase inhibitors in cancer therapy[J].Cancer Cell.2003(1)
  • 9D Maxwell Parkin.Global cancer statistics in the year 2000[J].Lancet Oncology.2001(9)
  • 10Johnstone RW.Histone-deacetylase inhibitors: novel drugs for the treatment of cancer[].Nature Reviews Drug Discovery.2002

共引文献1

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部